Abstract:Aims: SQSTMI/p62, as an autophagy marker, is a key molecule involved in the autophagy process. Recent studies have demonstrated that p62 has a close relationship with tumorigenesis and progression, but the impact of p62 on patients' survival has not been comprehensively understood. Therefore, we conducted this study to assess the expression level of p62 in tumor cells and the prognostic role of p62 expression in various malignant tumors. Methods: We searched PubMed, PubMed Central (PMC), Embase, Ovid and Web of Science databases and identified 30 eligible studies containing 14,072 patients to include in the meta-analysis. The p62 mRNA and protein expression profiles in various tumor tissues and normal tissues were presented according to the Human Protein Atlas (HPA) and the Gene Expression Profiling Interactive Analysis (GEPIA). We also tested the association between p62 mRNA level and patients' survival based on the Cancer Genome Atlas (TCGA) and the Human Protein Atlas (HPA) databases. Results: The expression levels of p62 mRNA and protein varied in different tissues. The p62 proteins were elevated and mainly located in the cytoplasm in some types of tumor compared with the normal tissues. The pooled results indicated that p62 overexpression in tumor tissues was associated with a worse prognosis. In the subgroup analysis, a significant relationship was observed between cytoplasmic p62 accumulation and both overall survival (HR 1.53, 95% CI: 1.03-2.27, P < 0.05) and disease-specific survival (HR 1.60, 95% CI: 1.15-2.24, P < 0.01). The relationship between p62 and worse survival was more evident in early stage tumors. P62 mRNA expression had no significant effect on the patient's survival except of liver cancer. Conclusions: The findings of this meta-analysis highlight the role of p62 as a useful prognostic biomarker for some types of tumor according to different clinicopathologic features, which may contribute to the selection of effective treatment methods for different malignant tumors.

Bcl-2-dependent upregulation of autophagy by sequestosome 1/p62 in vitro

Keap1 facilitates p62-mediated ubiquitin aggregate clearance via autophagy.

S-acylation of P62 Promotes P62 Droplet Recruitment into Autophagosomes in Mammalian Autophagy.

XIAP Facilitates Breast and Colon Carcinoma Growth Via Promotion of P62 Depletion Through Ubiquitination-Dependent Proteasomal Degradation

Autophagic Regulation of P62 is Critical for Cancer Therapy

p62 links the autophagy pathway and the ubiqutin–proteasome system upon ubiquitinated protein degradation

Requirement for P62 Acetylation in the Aggregation of Ubiquitylated Proteins under Nutrient Stress

The Homeostasis of p62/SQSTM1 Short Isoform Regulates Selective Autophagy

Interaction domains of p62: a bridge between p62 and selective autophagy.

P62 Links the Autophagy Pathway and the Ubiquitin–Proteasome System in Endothelial Cells during Atherosclerosis

P62/sqstm1/sequestosome-1 is an N-recognin of the N-end Rule Pathway Which Modulates Autophagosome Biogenesis

Bcl-2 Decreases the Affinity of SQSTM1/p62 to Poly-Ubiquitin Chains and Suppresses the Aggregation of Misfolded Protein in Neurodegenerative Disease

Knockdown of p62/sequestosome enhances ginsenoside Rh2-induced apoptosis in cervical cancer HeLa cells with no effect on autophagy

Sequestosome 1/p62 Protein is Associated with Autophagic Removal of Excess Hepatic Endoplasmic Reticulum in Mice

Downregulation of autophagy is associated with poor clinical outcome after immunochemotherapy in patients with diffuse large B-cell lymphoma

p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death

SQSTM1/p62 Loss Reverses the Inhibitory Effect of Sunitinib on Autophagy Independent of AMPK Signaling.

Overexpression of P62/sqstm1 Promotes the Degradations of Abnormally Accumulated PrP Mutants in Cytoplasm and Relieves the Associated Cytotoxicities Via Autophagy–lysosome-Dependent Way

Cytoplasmic SQSTM1/ P62 Accumulation Predicates a Poor Prognosis in Patients with Malignant Tumor.

p62 Promotes Malignancy of Hepatocellular Carcinoma by Regulating the Secretion of Exosomes and the Localization of beta-Catenin

S-acylation regulates SQSTM1/p62-mediated selective autophagy